These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28649691)

  • 1. Gluten and Aluminum Content in Synthroid
    Espaillat R; Jarvis MF; Torkelson C; Sinclair B
    Adv Ther; 2017 Jul; 34(7):1764-1769. PubMed ID: 28649691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions.
    Svirskis D; Lin SW; Brown H; Sangaroomthong A; Shin D; Wang Z; Xu H; Dean R; Vareed P; Jensen M; Wu Z
    Int J Pharm Compd; 2018; 22(2):164-171. PubMed ID: 29877863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Effectiveness of Persistent Use of a Name-Brand Levothyroxine (Synthroid®) vs. Persistent Use of Generic Levothyroxine on TSH Goal Achievement: A Retrospective Study Among Patients with Hypothyroidism in a Managed Care Setting.
    Wang L; Chen YJ; Grabner M; Nepal B; Bodhani A; Espaillat R; Hennessey JV
    Adv Ther; 2022 Jan; 39(1):779-795. PubMed ID: 34905150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum to: Gluten and Aluminum Content in Synthroid
    Espaillat R; Jarvis MF; Torkelson C; Sinclair B
    Adv Ther; 2017 Sep; 34(9):2178. PubMed ID: 28856598
    [No Abstract]   [Full Text] [Related]  

  • 5. The economic impact of switching from Synthroid for the treatment of hypothyroidism.
    Khandelwal N; Johns B; Hepp Z; Castelli-Haley J
    J Med Econ; 2018 May; 21(5):518-524. PubMed ID: 29458287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral thyroxine: variation in biologic action and tablet content.
    Sawin CT; Surks MI; London M; Ranganathan C; Larsen PR
    Ann Intern Med; 1984 May; 100(5):641-5. PubMed ID: 6546843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
    Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
    Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association Between Switching from Synthroid
    Hennessey JV; Espaillat R; Duan Y; Soni-Brahmbhatt S; Lage MJ; Singer P
    Adv Ther; 2021 Jan; 38(1):337-349. PubMed ID: 33113100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the Influence of Excipients on the Stability of Levothyroxine Sodium Pentahydrate.
    Kaur N; Suryanarayanan R
    Mol Pharm; 2021 Jul; 18(7):2683-2693. PubMed ID: 34061524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are multisource levothyroxine sodium tablets marketed in Egypt interchangeable?
    Abou-Taleb BA; Bondok M; Nounou MI; Khalafallah N; Khalil S
    Ann Endocrinol (Paris); 2018 Feb; 79(1):23-29. PubMed ID: 29289332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.
    Dong BJ; Hauck WW; Gambertoglio JG; Gee L; White JR; Bubp JL; Greenspan FS
    JAMA; 1997 Apr; 277(15):1205-13. PubMed ID: 9103344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biopharmaceutical comparison of two levothyroxine sodium products.
    Blouin RA; Clifton GD; Adams MA; Foster TS; Flueck J
    Clin Pharm; 1989 Aug; 8(8):588-92. PubMed ID: 2504532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro dissolution and in vivo bioavailability of commercial levothyroxine sodium tablets in the hypothyroid dog model.
    Wood RW; Martis L; Gillum AW; Roseman TJ; Lin L; Bernardo P
    J Pharm Sci; 1990 Feb; 79(2):124-7. PubMed ID: 2324959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment pattern and frequency of serum TSH measurement in users of different levothyroxine formulations: a population-based study during the years 2009-2015.
    Ferrara R; Ientile V; Arcoraci V; Ferrajolo C; Piccinni C; Fontana A; Benvenga S; Trifirò G
    Endocrine; 2017 Oct; 58(1):143-152. PubMed ID: 28155170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study in normal human volunteers to compare the rate and extent of levothyroxine absorption from Synthroid and Levoxine.
    Berg JA; Mayor GH
    J Clin Pharmacol; 1992 Dec; 32(12):1135-40. PubMed ID: 1487553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generic levothyroxine compared with synthroid in young children with congenital hypothyroidism.
    Lomenick JP; Wang L; Ampah SB; Saville BR; Greenwald FI
    J Clin Endocrinol Metab; 2013 Feb; 98(2):653-8. PubMed ID: 23293325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potency of brand name and generic levothyroxine.
    Stoffer SS; Szpunar WE
    JAMA; 1980 Oct; 244(15):1704-5. PubMed ID: 7411829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic equivalence of a levothyroxine sodium soft capsule manufactured using the new food and drug administration potency guidelines in healthy volunteers under fasting conditions.
    Colucci P; D'Angelo P; Mautone G; Scarsi C; Ducharme MP
    Ther Drug Monit; 2011 Jun; 33(3):355-61. PubMed ID: 21516059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans.
    Fish LH; Schwartz HL; Cavanaugh J; Steffes MW; Bantle JP; Oppenheimer JH
    N Engl J Med; 1987 Mar; 316(13):764-70. PubMed ID: 3821822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of excipients on the stability of levothyroxine sodium tablets.
    Das Gupta V; Odom C; Bethea C; Plattenburg J
    J Clin Pharm Ther; 1990 Oct; 15(5):331-6. PubMed ID: 2289935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.